These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4019956)

  • 1. Theophylline product and dosing interval selection for chronic asthma.
    Hendeles L; Weinberger M
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):285-91. PubMed ID: 4019956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the pharmacodynamics and pharmacokinetics of theophylline.
    Hendeles L; Massanari M; Weinberger M
    Chest; 1985 Aug; 88(2 Suppl):103S-111S. PubMed ID: 3893922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
    Hendeles L; Iafrate RP; Weinberger M
    Clin Pharmacokinet; 1984; 9(2):95-135. PubMed ID: 6370542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of a slow-release theophylline product.
    Hendeles L; Weinberger M
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):743-51. PubMed ID: 3534055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
    Weinberger MM
    Pharmacotherapy; 1984; 4(4):181-98. PubMed ID: 6483637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of product formulation to absorption of oral theophylline.
    Weinberger M; Hendeles L; Bighley L
    N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between rate and extent of absorption of oral theophylline from Uniphyl brand of slow-release theophylline and resulting serum concentrations during multiple dosing.
    Milavetz G; Vaughan LM; Weinberger MM; Harris JB; Mullenix TA
    J Allergy Clin Immunol; 1987 Nov; 80(5):723-9. PubMed ID: 3680816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma.
    Weinberger M; Hendeles L; Wong L
    J Pediatr; 1981 Jul; 99(1):145-52. PubMed ID: 7252652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma.
    Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG
    J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline absorption from sustained-release products: comparative steady-state bioavailability of once-daily Theo-Dur, Theo-24, and Uniphyl.
    Hurwitz A; Karim A; Burns TS
    J Clin Pharmacol; 1987 Nov; 27(11):855-61. PubMed ID: 3429692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule.
    Weinberger M; Hendeles L
    Pediatr Pharmacol (New York); 1983; 3(3-4):273-85. PubMed ID: 6429620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent inconsistent theophylline absorption from sustained release capsules.
    Uden DL; Schaber DE; Wyatt RA
    Clin Pediatr (Phila); 1987 Jun; 26(6):285-7. PubMed ID: 3581636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity.
    Hendeles L; Weinberger M; Milavetz G; Hill M; Vaughan L
    Chest; 1985 Jun; 87(6):758-65. PubMed ID: 3996063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
    Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
    Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pharmacokinetic concerns of 24-hour dosing with theophylline.
    Weinberger M
    Ann Allergy; 1986 Jan; 56(1):2-12. PubMed ID: 3511775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma.
    Pedersen S; Steffensen G
    J Pediatr; 1987 Jun; 110(6):953-9. PubMed ID: 3585612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratic absorption of theophylline from slow-release products in children.
    Szefler SJ
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):710-5. PubMed ID: 3534052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.